Skip to main navigation Skip to search Skip to main content

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People

  • Peter Pappas
  • , Robert J. Lentz
  • , Kayla R. Stover
  • , Nathan P. Wiederhold
  • , Monica I. Ardura
  • , John W. Baddley
  • , Nevert Badreldin
  • , Nathan C. Bahr
  • , Karen Bloch
  • , Carol A. Kauffman
  • , Rachel A. Miller
  • , Satish Mocherla
  • , Michael Saccente
  • , Ilan Schwartz
  • , Joshua Wolf
  • , Jennifer Loveless
  • , Andrej Spec
  • , Sandra R. Arnold

Research output: Contribution to journalArticlepeer-review

Abstract

This article is part of a larger clinical practice guideline on the management of histoplasmosis in adults, children, and pregnant people, developed by the Infectious Diseases Society of America. In this article, the panel provides recommendations for treatment of mild and moderate acute pulmonary histoplasmosis. The panel's recommendations are based upon evidence derived from systematic literature reviews and adhere to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach.

Original languageEnglish (US)
Pages (from-to)i39-i45
JournalClinical Infectious Diseases
Volume81
DOIs
StatePublished - Oct 15 2025

Keywords

  • antifungals
  • guideline
  • histoplasmosis
  • itraconazole
  • treatment

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of '2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People'. Together they form a unique fingerprint.

Cite this